Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Sun Pharma
Chattem Chemicals Inc.
Taro RX product details
Taro-DOXOrubicin Liposomal, Injection
Product Information
-
DIN:02493020
-
Active Ingredients :doxorubicin hydrochloride
-
Innovator Name:CAELYX®
-
Category:Antineoplastic Agent
-
Dosage form:Injection Concentrate (must be dlluted before use)
-
Strength:2 mg / mL
-
Route of Administration:intravenous
- Package size:
10 mL - UPC Code:
063691086692 -
Description :Taro-DOXOrubicin Liposomal (pegylated liposomal doxorubicin hydrochloride for injection) is provided as a sterile, translucent, red liposomal dispersion in 10 mL single-use vials.
-
Non-medicinal ingredients :ammonium sulphate, anhydrous ethanol, cholesterol, histidine, hydrochloric acid, hydrogenated soy phosphatidylcholine, MPEG-Distearoyl phosphatidylethanolamine, sodium hydroxide, sucrose, and water for injection
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here